Elizabeth Ness

1.0k citations
18 papers · 784 · h-index 13

Impact in

    • Protease and Inhibitor Mechanisms
  • Oncology top 10%
    • Peptidase Inhibition and Analysis
    • Global Cancer Incidence and Screening

Papers in

Elizabeth Ness

18 papers receiving 748 citations

Peers

Elizabeth Ness
Comparison fields: 5 of 98
  • Cancer Research 262
  • Oncology 341
  • Hematology 82
  • Immunology and Allergy 40
  • Molecular Biology 356
Replace Kenneth Villman with:
Kenneth Villman Sweden
Chiledum Ahaghotu United States
Jessica St. Louis United States
Bart C. Kuenen Netherlands
Robert L. DeWitty United States
Teresita Muñoz-Antonia United States
Chao‐Jung Tsao Taiwan
Yeşim Eralp Türkiye
E. E. Holdener Switzerland
Jan Schmielau Germany
Elizabeth Ness relative to Kenneth Villman Sweden Kenneth Villman's profile →
Citations per field
00.5×1.5×
Kenneth Villman · 1×
Citations per year

Countries citing papers authored by Elizabeth Ness

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Ness more than expected).

Fields of papers citing papers by Elizabeth Ness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Ness. The network helps show where Elizabeth Ness may publish in the future.

Co-authors

The 25 scholars most cited alongside Elizabeth Ness, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elizabeth Ness Line = papers co-authored together Elizabeth Ness links everyone, so they are left out of the graph.

All Works

18 of 18 papers shown
#Work
1 1998196
2 199694
3 200893
4
A Phase I study of LGD1069 in adults with advanced cancer.
199988
5
A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors.
200052
6 200447
7 201245
8 200231
9 200224
10 201723
11
Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
199823
12 201221
13 202013
14 201612
15
An innovative, web-based reporting system for serious adverse events developed by the cancer therapy evaluation program (CTEP), National Cancer Institute (NCI)
201110
16 20145
17 20225
18 20082

About Elizabeth Ness

Elizabeth Ness is a scholar working on Molecular Biology, General Health Professions, Public Health, Environmental and Occupational Health, Oncology and Cancer Research, having authored 18 papers that have together received 784 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (3 papers), Protease and Inhibitor Mechanisms (3 papers), Antioxidant Activity and Oxidative Stress (3 papers), Ethics in Clinical Research (3 papers), Peptidase Inhibition and Analysis (3 papers), Health Sciences Research and Education (2 papers), Health and Medical Research Impacts (2 papers) and Ethics in medical practice (2 papers). The work is most often cited by research in Cancer Research (262 citations), Oncology (341 citations), Hematology (82 citations), Immunology and Allergy (40 citations) and Molecular Biology (356 citations). Elizabeth Ness has collaborated with scholars based in United States. Frequent co-authors include Michael Hawkins, Slawomir Wojtowicz‐Praga, John L. Marshall, Mark Sale, Michael D. Johnson, Naiyer A. Rizvi, John B. Marshall, Rita A. Dickson, Thomas A. Chiodo and Elizabeth A. Calhoun. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Investigational New Drugs, Contemporary Clinical Trials and Journal of Medical Ethics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact